Press Announcements - FDA.gov

Press Announcements  FDA.gov

The FDA granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2r63bdx